A novel proton-fueled molecular gate-like delivery system has been constructed for controlled cargo release using i-motif quadruplex DNA as caps onto pore outlets of mesoporous silica nanoparticles. Start from simple conformation changes, the i-motif DNA cap can open and close the pore system in smart response to pH stimulus. Importantly, the opening/closing and delivery protocol is highly reversible and a partial cargo delivery can be easily controlled at will. A pH-switchable nanoreactor has also been developed to validate the potential of our system for on-demand molecular transport. This proof of concept might open the door to a new generation of carrier materials and could also provide a general route to use other functional nucleic acids/peptide nucleic acids as capping agents in the fields of versatile controlled delivery nanodevices.

The distinctive characteristics of mesoporous silica nanoparticles (MSPs) such as thermal stability, tunable pore sizes, large load capacity, and the ease of surface functionalization make these scaffolds ideal for the design of nanodevices and "on-command" delivery applications.[1] To date, several MSPbased controlled-release systems have been synthesized by using different kinds of capping agents including organic molecules, [2] nanoparticles, [3] and supramolecular assemblies.[4] "On-demand" release systems that respond to a range of stimuli, including redox, [2b, 4a, 5] pH or temperature, [6] enzymes, [7] competitive binding, [8] and photoirradiation [2a, 4b, 9] have recently been reported. Despite these burgeoning achievements, many of the existing capping systems have disadvantages such as the use of stimuli that are complicated and/or difficult to apply, poor applicability in aqueous solutions and biocompatibility, and the toxicity of the capping agents used. In particular, regardless of recent reports on capped MSPs that can be uncapped by certain enzymes [7] or carbohydrates, [10] the utility of MSP-based devices involving biomolecules for real delivery systems is still in its infancy. Therefore, the search for effective systems that, in particular, respond to internal biological stimuli still remains a big challenge in this field.Herein we describe the design and construction of a stimuli-responsive vehicle for intracellular drug delivery using a polyvalent nucleic acid/MSP "click" conjugate that responds to both external and endogenous activation. Nucleic acids have been recognized as attractive building blocks for nanotechnology and materials science owing to the remarkable specificity and versatility of these units.[11] The unique structural motif and self-recognition properties of duplex DNA, including temperature-dependent assembly, as well as the enzymatic recognition of specific encoded bases, may be applied as triggers for functional DNA manipulation. As shown in Figure 1, self-complementary duplex DNA was anchored to the openings of the MSPs and was utilized as a cap for trapping the guest molecules within the porous channels. The duplex DNA cap could be either denatured by heating or hydrolyzed by endonucleases, thus opening the nanopores and releasing the cargo. As a proof-of-principle experiment, rhodamine B was chosen as model molecule and deoxyribonuclease I (DNase I) was utilized as a representative endonuclease for DNA degradation. The opening of the capped system was tested by measuring the stimuli-triggered dye release from the MSPs. Importantly, we have demonstrated the successful loading of anticancer drugs camptothecin (CPT) and floxuridine (FUDR) into MSPs, and efficient intracellular controlled drug delivery in human cancer cells when endogenous nuclease was used as a stimulus.MCM-41 silica nanoparticles were prepared by following a base-catalyzed sol-gel procedure, [12] and the resulting porous silica nanoparticles (100 nm in diameter) that contain hexagonally arranged...

An enzyme responsive nanoparticle system that uses a DNA-gold nanoparticle (AuNP) assembly as the substrate has been developed for the simple, sensitive, and universal monitoring of restriction endonucleases in real time. This new assay takes advantage of the palindromic recognition sequence of the restriction nucleases and the unique optical properties of AuNPs and is simpler than the procedure previously described by by Xu et al. (Angew. Chem. Int. Ed. Engl. 2007, 46, 3468-3470). Because it involves only one type of ssDNA modified AuNPs, this assay can be directed toward most of the endonucleases by simply changing the recognition sequence found within the linker DNA. In addition, the endonuclease activity could be quantitatively analyzed by the value of the reciprocal of hydrolysis half time (t(1/2)(-1)). Furthermore, our new design could also be applied to the assay of methyltransferase activity since the methylation of DNA inhibits its cleavage by the corresponding restriction endonuclease, and thus, this new methodology can be easily adapted to high-throughput screening of methyltransferase inhibitors.

The midbody ring (MR) is asymmetrically segregated during asymmetric divisions of germline stem cells (GSCs) in Drosophila. Male GSCs, which inherit the mother centrosome, exclude the MR, whereas female GSCs, which inherit the daughter centrosome, inherit the MR. Moreover, stem cell identity correlates with the mode of MR inheritance.

Dopamine exhibits intriguing reactivity with silver nanoparticles through Ag-catechol interaction, which results in non-crosslinking AgNP aggregation, thus providing a novel approach for colorimetric detection of dopamine with high sensitivity and selectivity.

A novel light-operated vehicle for targeted intracellular drug delivery is constructed using photosensitizer-incorporated G-quadruplex DNA-capped mesoporous silica nanoparticles. Upon light irradiation, the photosensitizer generates ROS, causing the DNA capping to be cleaved and allowing cargo to be released. Importantly, this platform makes it possible to develop a drug-carrier system for the synergistic combination of chemotherapy and PDT for cancer treatment with spatial/temporal control. Furthermore, the introducing of targeting ligands further improves tumor targeting efficiency. The excellent biocompatibility, cell-specific intracellular drug delivery, and cellular uptake properties set up the basis for future biomedical application that require in vivo controlled, targeted drug delivery.

Metal ions play important roles in amyloid aggregation and neurotoxicity. Metal-ion chelation therapy has been used in clinical trials for Alzheimer's disease (AD) treatment. However, clinical trial studies have shown that long-term use of metal chelator can cause adverse side effect, subacute myelo-optic neuropathy. Nanoparticle engineering processes have become promising approaches for efficiently drugs delivery. A series of modified mesoporous silica nanoparticles (MSNs) using redox, pH, competitive binding, light, and enzyme as actuators have been demonstrated. Recently, significant advances in sensing oxidative stress have been made by taking advantage of specific chemistry between cellular oxidants such as H(2) O(2) . Here we report a biocompatible delivery platform by using H(2) O(2) responsive controlled-release system to realize target delivery of AD therapeutic metal chelator. The advantage of this novel strategy is that metal chelator can only be released by the increased levels of H(2) O(2) , thus, it would not interfere with the healthy metal homeostasis and can overcome strong side effect of metal chelator after long-term use. By taking advantage of the good biocompatibility, cellular uptake properties, and efficient intracellular release of metal chelators, the delivery system is promising for future in vivo controlled-release biomedical applications.

Asymmetric stem cell division is often accompanied by stereotypical inheritance of the mother and daughter centrosomes. However, it remains unknown whether and how stem cell centrosomes are uniquely regulated and how this regulation may contribute to stem cell fate. Here we identify Klp10A, a microtubule-depolymerizing kinesin of the kinesin-13 family, as the first protein enriched in the stem cell centrosome in Drosophila male germline stem cells (GSCs). Depletion of klp10A results in abnormal elongation of the mother centrosomes in GSCs, suggesting the existence of a stem cell-specific centrosome regulation program. Concomitant with mother centrosome elongation, GSCs form asymmetric spindle, wherein the elongated mother centrosome organizes considerably larger half spindle than the other. This leads to asymmetric cell size, yielding a smaller differentiating daughter cell. We propose that klp10A functions to counteract undesirable asymmetries that may result as a by-product of achieving asymmetries essential for successful stem cell divisions.DOI: http://dx.doi.org/10.7554/eLife.20977.001